Lead-induced inclusion bodies. Solubility, amino acid content, and relationship to residual acidic nuclear proteins.
D000596:Amino Acids / Q000032:analysis*; D000818:Animals; D002499:Centrifugation, Density Gradient; D002614:Chelating Agents / Q000494:pharmacology; D004247:DNA / Q000032:analysis; D006657:Histones / Q000032:analysis; D006851:Hydrochloric Acid / Q000494:pharmacology; D002479:Inclusion Bodies / Q000032:analysis*; D007668:Kidney / Q000378:metabolism / Q000473:pathology; D007854:Lead / Q000032:analysis*; D007855:Lead Poisoning / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008854:Microscopy, Electron; D009698:Nucleoproteins / Q000032:analysis*; D012313:RNA / Q000032:analysis; D051381:Rats; D012965:Sodium Chloride / Q000494:pharmacology; D012967:Sodium Dodecyl Sulfate / Q000494:pharmacology; D012972:Sodium Hydroxide / Q000494:pharmacology; D012995:Solubility; D012997:Solvents / Q000494:pharmacology; D014508:Urea / Q000494:pharmacology
D000596:Amino Acids; D002614:Chelating Agents; D006657:Histones; D009698:Nucleoproteins; D012997:Solvents; D007854:Lead; D012967:Sodium Dodecyl Sulfate; D012965:Sodium Chloride; D012972:Sodium Hydroxide; D012313:RNA; D014508:Urea; D004247:DNA; D006851:Hydrochloric Acid